Elevance Health Inc. (ELV) Stock Score, Valuation & Financial Research
Elevance Health Inc. is in the Healthcare sector and Medical - Healthcare Plans industry. It is reviewed using Wall Street Score's company-strength, valuation, growth and financial-health framework. The current Wall Street Score is 50/100.
Quick answer for ELV
Elevance Health Inc. currently has a Wall Street Score of 50/100. The stored market price is $418.72. Its financial score is 34/100. Its valuation score is 72/100. The latest WSS change is +0.6 points. These figures are a research snapshot, not a buy or sell recommendation.
What Elevance Health Inc. does
Operating as a major health benefits organization, Elevance Health Inc. commits to guiding consumers, families, and communities across their entire health and wellness path. It facilitates access to vital care, assistance, and tools designed to enable healthier living for approximately 118 million individuals. The company's comprehensive offerings span medical, digital, pharmaceutical, behavioral health, clinical, and other care solutions. Founded in 1944 and based in Indianapolis, Indiana, this entity adopted its current name, Elevance Health Inc., in June 2022, having previously operated as Anthem, Inc.
ELV financial snapshot
- Wall Street Score:
- 50/100
- Current price:
- $418.72
- Market capitalization:
- $90.81B
- Revenue:
- $201.11B
- Net income:
- $4.96B
- Free cash flow:
- $3.17B
- Cash:
- $10.23B
- Total debt:
- $31.04B
- EPS:
- 22.50
- P/E ratio:
- 18.6x
- Financial score:
- 34/100
- Valuation score:
- 72/100
- Revenue score:
- 34/100
What stands out
- Reported year-over-year revenue growth is +0.0%.
- Free cash flow is $3.17B, showing positive cash generation.
- The balance sheet shows $10.23B of cash versus $31.04B of total debt, so leverage deserves attention.
- The latest Wall Street Score change is +0.6 points: ELV increased 0.6 points because Valuation improved by 2.3 points.
What the numbers mean
Its current valuation score is 72/100, which Wall Street Score classifies as strong within the model's valuation framework.
The financial score is 34/100. This is a starting point for reviewing liquidity, leverage and cash-flow strength rather than a stand-alone recommendation.
A strong company and an attractive stock price are not always the same thing. Revenue, earnings, free cash flow, debt, management quality, competitive advantage and valuation should be considered together. Wall Street Score organizes these inputs into a consistent research framework so investors can identify what deserves deeper review.
Data freshness: Financial data last refreshed 2026-09-07.
How to research ELV
Start by understanding how the company makes money. Then compare revenue and earnings trends, cash generation, debt, liquidity and valuation. Review the company's latest filings and earnings reports before acting on any score or model estimate.
Learn how to analyze a stock · Read the Wall Street Score methodology · Browse other stocks
Data may change as company filings and market prices update. Educational research only; not a buy or sell recommendation.